Jo Eun Jun, Yang Ho Jik, Kim Jong Hwan
From the Department of Plastic and Reconstructive Surgery, College of Medicine, Eulji University, Daejeon, Korea.
J Craniofac Surg. 2015 Jan;26(1):e33-6. doi: 10.1097/SCS.0000000000001293.
The objectives of surgical treatment for orbital fracture are to return soft tissue to its original position as well as reduce and fix the bone fragments properly. Reduction of the orbital bone through a subciliary or conjunctival incision and reduction using a urinary balloon catheter were simultaneously performed on 53 patients between 2010 and 2013. Fibrin glue was used to attach the reduced bone fragments. These patients had less than 2 cm(2) of bone defect and showed diplopia, eye movement limitation, and enophthalmos. Diplopia, eye movement limitation, and enophthalmos were each reduced to 3/32, 2/25, and 2/48, respectively. There were no adverse effects, such as infection or hematoma, and because implants were not used, there was no possibility of its extrusion or foreign body reaction. The operation time decreased compared with when using an implant, and the bone fragments remained in a fixed position even after removing the urinary balloon catheter. Therefore, the use of fibrin glue proved to be effective in orbital floor fractures.
眼眶骨折手术治疗的目的是将软组织恢复到原来的位置,并妥善复位和固定骨折碎片。2010年至2013年期间,对53例患者同时进行了经睫下或结膜切口的眼眶骨复位以及使用尿管球囊导管进行复位。使用纤维蛋白胶固定复位后的骨折碎片。这些患者的骨缺损小于2平方厘米,表现为复视、眼球运动受限和眼球内陷。复视、眼球运动受限和眼球内陷分别降至3/32、2/25和2/48。没有感染或血肿等不良反应,并且由于未使用植入物,不存在其挤出或异物反应的可能性。与使用植入物时相比,手术时间缩短,并且即使在移除尿管球囊导管后,骨折碎片仍保持在固定位置。因此,事实证明纤维蛋白胶在眶底骨折治疗中是有效的。